How FOXO4-DRI Works

FOXO4-DRI is a custom-engineered peptide designed to target senescent cells—frequently called “zombie cells”—which have stopped dividing but refuse to die, leaking chronic inflammatory signals that age surrounding tissue. The peptide uses a D-retro-inverso (DRI) configuration, meaning its amino acid sequence is reversed and flipped to mirror human proteins perfectly while resisting the body’s natural enzyme breakdown:

• Disrupts the FOXO4-p53 Survival Complex: In senescent cells, the transcription factor FOXO4 binds tightly to the tumor suppressor protein p53, trapping p53 in the cell nucleus. This interaction keeps the cell alive and prevents it from executing its natural cell-death program. FOXO4-DRI works by physically competing with natural FOXO4, kicking it off the p53 binding site.

• Triggers Targeted Apoptosis (Cell Death): Once FOXO4-DRI excludes FOXO4 from the complex, the freed p53 protein migrates out of the cell nucleus and travels straight to the mitochondria. This action immediately triggers apoptosis (programmed cell death), destroying the senescent cell while leaving healthy, dividing cells completely unharmed.

• Neutralizes the Toxic SASP Profile: Senescent cells damage the body by secreting a toxic chemical mix called the Senescence-Associated Secretory Phenotype (SASP), which contains destructive pro-inflammatory cytokines, chemokines, and tissue-degrading matrix metalloproteinases. By selectively clearing these cells, FOXO4-DRI helps researchers study systemic inflammation reduction and structural tissue rejuvenation.

• Supports Tissue Stem Cell Regeneration: Removing senescent cells frees up biological space and resources within the surrounding extracellular matrix. In aging tissue models, this clearance stimulates localized tissue stem cells to multiply and replace old, dysfunctional tissue with healthy, active cells.

Chemical Properties